Evidence map›Paper›PMID 30606049›Full record

ArticleThe American journal of psychiatry2019

Connectome-Based Prediction of Cocaine Abstinence.

Sarah W Yip, Dustin Scheinost, Marc N Potenza, Kathleen M Carroll

Abstract read
In one paragraph

Article in The American journal of psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 125 papers.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

125 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Predicting individual incubation of opioid craving by whole-brain functional connectivity.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sarah W YipThe Department of Psychiatry (Yip, Potenza, Carroll), the Child Study Center (Yip, Scheinost, Potenza), the Department of Radiology and Biomedical Imaging (Scheinost), and the Department of Neuroscience (Potenza), Yale School of Medicine, New Haven, Conn.; and the Connecticut Mental Health Center, New Haven, Conn. (Potenza).
Dustin ScheinostThe Department of Psychiatry (Yip, Potenza, Carroll), the Child Study Center (Yip, Scheinost, Potenza), the Department of Radiology and Biomedical Imaging (Scheinost), and the Department of Neuroscience (Potenza), Yale School of Medicine, New Haven, Conn.; and the Connecticut Mental Health Center, New Haven, Conn. (Potenza).
Marc N PotenzaThe Department of Psychiatry (Yip, Potenza, Carroll), the Child Study Center (Yip, Scheinost, Potenza), the Department of Radiology and Biomedical Imaging (Scheinost), and the Department of Neuroscience (Potenza), Yale School of Medicine, New Haven, Conn.; and the Connecticut Mental Health Center, New Haven, Conn. (Potenza).
Kathleen M CarrollThe Department of Psychiatry (Yip, Potenza, Carroll), the Child Study Center (Yip, Scheinost, Potenza), the Department of Radiology and Biomedical Imaging (Scheinost), and the Department of Neuroscience (Potenza), Yale School of Medicine, New Haven, Conn.; and the Connecticut Mental Health Center, New Haven, Conn. (Potenza).

Funding

TSF to enhance treatment of cocaine dependenceP50DA009241 · NIDA · YALE UNIVERSITY · PI CARROLL, KATHLEEN M. · 1994 to 2018
$40.5M
Neural mechanisms of CBT in cocaine dependence (Gender Differences Supplement)R01DA035058 · NIDA · YALE UNIVERSITY · PI CARROLL, KATHLEEN M., POTENZA, MARC N · 2013 to 2016
$2.3M
Neural mechanisms of galantamine treatment for cocaine dependenceK01DA039299 · NIDA · YALE UNIVERSITY · PI YIP, SARAH · 2016 to 2020
$905k
NIDA NIH HHS K01 DA039299NIDA NIH HHS P50 DA009241NIDA NIH HHS R01 DA035058
6 · The paper itself

Abstract

objectiveThe authors sought to identify a brain-based predictor of cocaine abstinence by using connectome-based predictive modeling (CPM), a recently developed machine learning approach. CPM is a predictive tool and a method of identifying networks that underlie specific behaviors ("neural fingerprints").

methodsFifty-three individuals participated in neuroimaging protocols at the start of treatment for cocaine use disorder, and again at the end of 12 weeks of treatment. CPM with leave-one-out cross-validation was conducted to identify pretreatment networks that predicted abstinence (percent cocaine-negative urine samples during treatment). Networks were applied to posttreatment functional MRI data to assess changes over time and ability to predict abstinence during follow-up. The predictive ability of identified networks was then tested in a separate, heterogeneous sample of individuals who underwent scanning before treatment for cocaine use disorder (N=45).

resultsCPM predicted abstinence during treatment, as indicated by a significant correspondence between predicted and actual abstinence values (r=0.42, df=52). Identified networks included connections within and between canonical networks implicated in cognitive/executive control (frontoparietal, medial frontal) and in reward responsiveness (subcortical, salience, motor/sensory). Connectivity strength did not change with treatment, and strength at posttreatment assessment also significantly predicted abstinence during follow-up (r=0.34, df=39). Network strength in the independent sample predicted treatment response with 64% accuracy by itself and 71% accuracy when combined with baseline cocaine use.

conclusionsThese data demonstrate that individual differences in large-scale neural networks contribute to variability in treatment outcomes for cocaine use disorder, and they identify specific abstinence networks that may be targeted in novel interventions.

Indexed as

ConnectomeAdultBehavior TherapyBrainCholinesterase InhibitorsCocaine-Related DisordersCognitionExecutive FunctionFemaleFunctional NeuroimagingGalantamineHumansIndividualityMachine LearningMagnetic Resonance ImagingMaleCholinesterase InhibitorsGalantamineCocaineCognitive NeurosciencePsychoactive Substance Use Disorder

Identifiers

PMID30606049
PMCPMC6481181

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.